Hims & Hers Health Inc. buy Morgan Stanley
Start price
17.12.24
/
50%
€30.24
Target price
17.12.25
€39.97
Performance (%)
4.83%
Price
12.12.25
€31.70
This prediction will end soon
Summary
This prediction is currently active. With a performance of 4.83%, the BUY prediction by Morgan_Stanley for Hims & Hers Health Inc. is trending in the right direction. This prediction currently runs until 17.12.25. The prediction end date can be changed by Morgan_Stanley at any time. Morgan_Stanley has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m |
|---|---|---|
| Hims & Hers Health Inc. | -5.851% | -5.851% |
| iShares Core DAX® | 0.734% | -0.964% |
| iShares Nasdaq 100 | -2.686% | -2.409% |
| iShares Nikkei 225® | -2.261% | -4.038% |
| iShares S&P 500 | -1.346% | -1.510% |
Comments by Morgan_Stanley for this prediction
In the thread Hims & Hers Health Inc. diskutieren
Hims & Hers Health, Inc. (NYSE: HIMS) is now covered by analysts at Morgan Stanley. They set an "overweight" rating and a $42.00 price target on the stock.
Ratings data for HIMS provided by MarketBeat